Cite
HARVARD Citation
Shirasawa, M. et al. (2022). Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer. European journal of cancer. pp. 1-10. [Online].